OMEGA HEALTHCARE INVESTORS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.64 USD | +0.02% |
|
-0.33% | -0.07% |
| May. 09 | RBC Lifts Price Target on Omega Healthcare Investors to $32 From $31, Keeps Sector Perform Rating | MT |
| May. 03 | Transcript : Omega Healthcare Investors, Inc., Q1 2024 Earnings Call, May 03, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company is one of the best yield companies with high dividend expectations.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- One of the major weak points of the company is its financial situation.
- The company benefits from high valuations in earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.07% | 7.57B | B | ||
| +13.10% | 60.56B | A- | ||
| +0.88% | 14B | A | ||
| -7.89% | 6.01B | B- | ||
| +12.58% | 3.56B | C- | ||
| +0.70% | 3.32B | C+ | ||
| -5.50% | 3.15B | B+ | ||
| +5.19% | 3.01B | C | ||
| +18.78% | 2.89B | C- | ||
| -13.73% | 2.48B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- OHI Stock
- Ratings Omega Healthcare Investors, Inc.
